Robert L. Avery

14.0k citations
81 papers · 10.2k · 9 hit papers · h-index 33

Impact in

Papers in

    • Retinal Diseases and Treatments 46
    • Retinal and Optic Conditions 14
    • Intraocular Surgery and Lenses 8
    • Ocular Diseases and Behçet’s Syndrome 7
    • Glaucoma and retinal disorders 4
    • Retinal and Macular Surgery 14
    • Retinal Imaging and Analysis 10

Robert L. Avery

78 papers receiving 9.7k citations

Robert L. Avery's Hit Papers

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study 2024 · 60 citations
600+10+21Years since publication10002.0k3.0k

Peers

Robert L. Avery
Comparison fields: 5 of 115
  • Ophthalmology 6.7k
  • Radiology, Nuclear Medicine and Imaging 3.3k
  • Clinical Biochemistry 238
  • Molecular Biology 2.3k
  • Cancer Research 381
Replace Michael J. Tolentino with:
Michael J. Tolentino United States
Paul G. Arrigg United States
Hitoshi Takagi Japan
A.P. Adamis United States
Sergio Caballero United States
Christopher M. Aderman United States
Sean F. Hackett United States
Izumi Suzuma Japan
Gregory S. Robinson United States
Robert L. Avery relative to Michael J. Tolentino United States Michael J. Tolentino's profile →
Citations per field
00.5×6.4×
Michael J. Tolentino · 1×
Citations per year

Countries citing papers authored by Robert L. Avery

Since Specialization
Citations

This map shows the geographic impact of Robert L. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Avery more than expected).

Fields of papers citing papers by Robert L. Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Avery. The network helps show where Robert L. Avery may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert L. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert L. Avery Line = papers co-authored together Robert L. Avery links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Hit paper breakdown →
19943212
2
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Hit paper breakdown →
2006985
3
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
Hit paper breakdown →
1995928
4
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Hit paper breakdown →
2006645
5 2007325
6 2006303
7
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
Hit paper breakdown →
2014294
8 2007288
9
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration
Hit paper breakdown →
2018283
10 2006281
11 1996274
12
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
Hit paper breakdown →
2017255
13 2007209
14 2014200
15 2015168
16
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
Hit paper breakdown →
2023106
17 200888
18 201587
19 201373
20 201366

About Robert L. Avery

Robert L. Avery is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Neurology and Epidemiology, having authored 81 papers that have together received 10.2k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (46 papers), Retinal and Macular Surgery (14 papers), Retinal and Optic Conditions (14 papers), Retinal Imaging and Analysis (10 papers), Intraocular Surgery and Lenses (8 papers), Ocular Diseases and Behçet’s Syndrome (7 papers), Glaucoma and retinal disorders (4 papers) and Retinal Development and Disorders (4 papers). The work is most often cited by research in Ophthalmology (6.7k citations), Radiology, Nuclear Medicine and Imaging (3.3k citations), Clinical Biochemistry (238 citations), Molecular Biology (2.3k citations) and Cancer Research (381 citations). Robert L. Avery has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Dante J. Pieramici, Alessandro Castellarin, Ma'an Nasir, Melvin Rabena, Lloyd Paul Aiello, Paul G. Arrigg, Matthew Giust, Louis R. Pasquale, Bruce A. Keyt and Sabera T. Shah. Their work appears in journals such as Retina, Investigative Ophthalmology & Visual Science, Ophthalmology, Ophthalmic surgery, lasers & imaging retina and British Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact